Viatris soars 14% on S&P amid new acquisition plans



The shares of pharma giant Viatris Inc. surged more than 14% on Monday as the recently announced acquisition plans pushed positive sentiment among investors.

Ahead of the opening bell, Viatris confir…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento